Temasek-Led €255M Investment Round in ITM Isotope Technologies Munich SE
June 5, 2023
Temasek led a €255 million equity investment round in ITM Isotope Technologies Munich SE, with participation from QIA, BlackRock Alternatives, Nextech, ATHOS and Carbyne. The proceeds (mostly primary capital with a minority secondary component) will advance ITM's targeted radionuclide therapy pipeline, support late-stage clinical development of ITM-11, and expand GMP manufacturing capacity for n.c.a. 177Lu and 225Ac while bolstering commercial infrastructure.
- Buyers
- Temasek, QIA, BlackRock Alternatives, Nextech, ATHOS, Carbyne
- Targets
- ITM Isotope Technologies Munich SE
- Industry
- Biotechnology
- Location
- Bavaria, Germany
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.